Increasing Prevalence of Neurological Disorders to Boost Demand for Neuromodulation Devices

Neuromodulation is the process of regulating neural activity through delivering a sensory stimulus, including electrical stimulation, to a certain area, like the brain's cortex, and thereby controlling it. It can be applied to the motor or sensory systems, as well as the central nervous system. It is a very sophisticated form of neurostimulation.

Neuromodulation devices are used in many medical field. They help to control muscle movement, muscle spasms, muscle contractions, and muscle fatigue. They also help with muscle weakness. There are various neurostimulation devices that are available on the market. They work by providing a signal to the brain to cause a reaction or to allow a person to make a response. These signals are called neurotransmitters, and they come in different intensities and frequencies. There are many kinds of neurostimulation devices that are available on the market. Spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric electric stimulators are some of the types of devices used for neuromodulation.

Neuromodulation helps improve your body's ability to do its functions in a more effective way. It is used to treat many problems related to the nervous system. It can be used for pain relief, epilepsy, depression, epilepsy, Alzheimer's, stroke, and multiple sclerosis. It is even used for cancer patients. Increasing prevalence of neurological disorders is expected to propel growth of the global neuromodulation devices. For instance, according to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020.

The market in U.S. is also witnessing approval and launch of new products from major market players. For instance, in March 2020, Neuronetics, Inc., a commercial stage medical technology company developing solutions for the treatment of psychiatric disorders, received Breakthrough Device Designation for its NeuroStar Advanced Therapy System for the treatment of bipolar depression, from the U.S. Food and Drug Administration.  

 

Comments

Popular posts from this blog

Pregnancy Testing Devices are proving to be revolutionary tool with hassle-free testing and rapid results

New Study Highlights Development of Algae That Rapidly Produces Natural Astaxanthin

Growing need for real-time visibility into the on-road and off-road activities is escalating demand for automotive telematics